Mysore varsity in charge V-C held guilty of sexual abuse

DHNS
September 20, 2017

Bengaluru, Sept 20: An internal probe conducted by the University of Mysore (UoM) has found Prof Dayanand Mane, senior professor and in-charge vice-chancellor, guilty of sexual harassment charges levelled by several female students of the varsity.

The Internal Complaints Committee of UoM, which probed the charges of sexual harassment against Mane, has recommended to the varsity to “withdraw/divest Mane of all powered positions, including chairmanship and deanship, with immediate effect”.

The Committee has also recommended to UoM to cancel Mane’s Research Guideship, as “the victims are research scholars”. The Committee, which initiated the probe at the behest of the Karnataka State Women’s Commission on January 21, 2016, met 17 times before submitting its report to the varsity on August 31, 2016. DH has accessed a copy of the report.

The five-member committee headed by professor and chairperson of Food Science and Nutrition, Asna Urooj, has made three major recommendations and 23 observations, despite the main victim turning hostile.

The Committee has observed that Mane has been acting as a sexual predator, victimising female students, especially those from oppressed sections, North Eastern states and from abroad. An unopened packet of condom discovered in his office drawer last year, is one of the main incriminating evidences against him, as per the report.

Witness account

The witnesses -- teaching and non-teaching faculty, and students, who deposed before the Committee -- stated that Mane would verbally abuse his research scholars in derogatory language.

While a student with disabilities was all the time humiliated, another research scholar alleged that he was forced to divorce his wife because of Mane’s conduct, the report stated.

While a Bangladeshi Law student is learnt to have levelled molestation charges against Mane, several female students have complained that he used to call them over phone and offer them rides in his car, the report said.

Secrecy & inaction

The 11-page report was kept under wraps since its submission last August. The then V-C of UoM, K S Rangappa, did not take any action against Mane. Instead, the ICC was dissolved much before its term ended in September 2017. Mane was only acting as the chairman of Department of studies in public administration at that time.

After Rangappa’s term ended in January this year, the committee members submitted a copy of the report to his successor, (acting V-C) Yashvantha Dongre. But he, too, did not act on the report.

Notwithstanding inaction from all quarters, the panel members then sent the report to Governor Vajubhai Vala in January, appealing to him to come to the rescue of scores of female students. Instead, Mane, despite the incriminating evidence against him, was elevated as the varsity’s in-charge V-C in March this year.

Comments

Harschandra
 - 
Thursday, 21 Sep 2017

shame man shame.

 

RAHU attacked KSOU earlier and now it is KETU attacking UOM.

Dr Govinda
 - 
Thursday, 21 Sep 2017

If VC mane has done this, who is to bell the cat ???

 

I doubt it.

Danish
 - 
Wednesday, 20 Sep 2017

Big shame.. all these happening in education instituion?

Hari
 - 
Wednesday, 20 Sep 2017

Maniac. u should treat students like your own kids.. Shame on you

Kumar
 - 
Wednesday, 20 Sep 2017

Recently many news came like this. We parents are scared to send our daughter to school/college

Ganesh
 - 
Wednesday, 20 Sep 2017

Moron... should get proper punishment

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 5,2020

Mangaluru, Jul 5: A COVID-19 patient escaped from a hospital in Mangaluru on Sunday, Mangaluru Commissioner of Police Vikas Kumar.

A total of 1,925 cases of COVID-19 and 37 deaths recorded in Karnataka in the last 24 hours, taking the total number of cases to 23,474.

The health department informed that the death toll rose to 372 while active cases stood at 13,251 in the state.

According to the Union Health Ministry, India has recorded 6,73,165 numbers of COVID-19 cases and 19,268 deaths. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 10,2020

Bengaluru, Jan 10: The National Commission for Scheduled Tribes (NCST), which met with officials of the Social Welfare Department Thursday, has urged the state government to increase the reservation provided to the ST community.

The Commission's suggestion comes even as a committee headed by Justice Nagamohan Das is currently studying a demand for increase of reservation for the community from the existing 3% to 7.5%.

Addressing mediapersons on Thursday, Commission Chairperson Nand Kumar Sai, said the Commission had discussed the issue with the Social Welfare Department, Karnataka, asking officials to expedite the process.

In response to this suggestion, Social Welfare Department Principal Secretary G Kumar Naik said the government would take a call based on the Nagamohan Das Committee's report.

A meeting was held between members of the National ST Commission and the Social Welfare Department Thursday with regard to various projects taken up by the department.

In June last year, the then Kumaraswamy-led coalition government constituted the Justice Nagamohan Das Committee, after protests from members of the Valmiki community for an increase in reservation to 7.5%. At present, Karnataka provides 15% reservation for SCs, 3% for STs and 32% for other backward classes (OBC).

The national commission also urged the state government to ensure permanent faculty in all the 824 residential institutions run by the department. At present, as much as 50% of the faculty in these institutions have been hired on a contractual basis. "We have assured that the recruitment will be done in a short time," Naik told mediapersons.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.